To get a sense of who is truly in control of Immutep Limited (ASX:IMM), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the pie ...

As Immutep’s (IMMP) efti program has advanced into Phase III development, the Company has continued to grow and evolve its team. As part of ...

SYDNEY, Australia - Immutep Limited (NASDAQ:IMMP), a biotechnology company specializing in pharmaceutical preparations with a market capitalization of $285 million, has disclosed its quarterly ...